A NEW CLASS of therapeutic agents known as "antisense" drugs is likely to become available to physicians within the next few months. These drugs operate at the molecular level, interrupting the process by which disease-causing proteins are produced.
No takes yet. Share an insight, caveat, or question.
C. Marwick (1998) studied this question.